Cargando…

CRISPR/Cas-Based Approaches to Study Schizophrenia and Other Neurodevelopmental Disorders

The study of diseases of the central nervous system (CNS) at the molecular level is challenging because of the complexity of neural circuits and the huge number of specialized cell types. Moreover, genomic association studies have revealed the complex genetic architecture of schizophrenia and other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurishev, Artemiy O., Karpov, Dmitry S., Nadolinskaia, Nonna I., Goncharenko, Anna V., Golimbet, Vera E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820593/ https://www.ncbi.nlm.nih.gov/pubmed/36613684 http://dx.doi.org/10.3390/ijms24010241

Ejemplares similares

Cellular Models in Schizophrenia Research
por: Abashkin, Dmitrii A., et al.
Publicado: (2021)

Development of a self-replicating plasmid for non-toxic expression of CRISPR-repressors to study schizophrenia-risk genes
por: Abashkin, D., et al.
Publicado: (2022)

ASCL1 Is Involved in the Pathogenesis of Schizophrenia by Regulation of Genes Related to Cell Proliferation, Neuronal Signature Formation, and Neuroplasticity
por: Abashkin, Dmitrii A., et al.
Publicado: (2023)

Fighting Tuberculosis: In Search of a BCG Replacement
por: Nadolinskaia, Nonna I., et al.
Publicado: (2022)

Development of a cellular model to study L-DOPA decarboxylase deregulation in the pathogenesis of schizophrenia
por: Kurishev, A., et al.
Publicado: (2023)

CRISPR Interference of Adenylate Cyclases from Mycobacterium tuberculosis
por: Nadolinskaia, N. I., et al.
Publicado: (2021)

Yeast Rpn4 Links the Proteasome and DNA Repair via RAD52 Regulation
por: Spasskaya, Daria S., et al.
Publicado: (2020)

Vaccines Against Tuberculosis: Problems and Prospects (Review)
por: Nadolinskaia, N. I., et al.
Publicado: (2020)

A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing
por: Bell, Scott, et al.
Publicado: (2016)

Novel Approaches for Identifying the Molecular Background of Schizophrenia
por: Golov, Arkadiy K., et al.
Publicado: (2020)

Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems
por: Karpov, Dmitry S., et al.
Publicado: (2022)

Decanalization mediating gene-environment interactions in schizophrenia and other psychiatric disorders with neurodevelopmental etiology
por: Burrows, Emma L., et al.
Publicado: (2013)

Neurodevelopmental hypothesis of schizophrenia
por: Owen, Michael J., et al.
Publicado: (2011)

Focus on autism and other neurodevelopmental disorders
por: Ryabinin, Andrey E.
Publicado: (2021)

Fetal alcohol spectrum disorder: neurodevelopmentally and behaviorally indistinguishable from other neurodevelopmental disorders
por: Lange, Shannon, et al.
Publicado: (2019)

Profiling haplotype specific CpG and CpH methylation within a schizophrenia GWAS locus on chromosome 14 in schizophrenia and healthy subjects
por: Alfimova, Margarita, et al.
Publicado: (2020)

Gender Identity Disorder and Schizophrenia: Neurodevelopmental Disorders with Common Causal Mechanisms?
por: Rajkumar, Ravi Philip
Publicado: (2014)

Progress and Prospects of CRISPR/Cas Systems in Insects and Other Arthropods
por: Sun, Dan, et al.
Publicado: (2017)

Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders
por: Jansson, Anna K., et al.
Publicado: (2023)

Employing CRISPR/Cas Technology for the Improvement of Potato and Other Tuber Crops
por: Tussipkan, Dilnur, et al.
Publicado: (2021)

CRISPR/Cas therapeutic strategies for autosomal dominant disorders
por: Caruso, Salvatore Marco, et al.
Publicado: (2022)

CRISPR-Cas systems for diagnosing infectious diseases
por: Kostyusheva, Anastasiya, et al.
Publicado: (2022)

Tourette syndrome and other neurodevelopmental disorders: a comprehensive review
por: Cravedi, Elena, et al.
Publicado: (2017)

CNS critical periods: implications for dystonia and other neurodevelopmental disorders
por: Li, Jay, et al.
Publicado: (2021)

Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
por: Patsali, Petros, et al.
Publicado: (2019)

Editorial: Current approaches to CRISPR/Cas9 delivery
por: Uludağ, Hasan, et al.
Publicado: (2022)

Editorial: Updates on the Neuropathology of Sudden Unexplained Perinatal Death and Other Neurodevelopmental Disorders
por: Lavezzi, Anna Maria, et al.
Publicado: (2021)

CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases
por: Khan, Faheem Ahmed, et al.
Publicado: (2016)

CRISPR-Cas Systems in Gut Microbiome of Children with Autism Spectrum Disorders
por: Zakharevich, Natalia V., et al.
Publicado: (2022)

CRISPR-Cas Technology In and Out of the Classroom
por: Dahlberg, Lina, et al.
Publicado: (2018)

Applications of CRISPR-Cas9 in Alzheimer’s Disease and Related Disorders
por: De Plano, Laura M., et al.
Publicado: (2022)

Neurodevelopmental Disorders, Schizophrenia Spectrum Disorders and Catatonia: The “Iron Triangle” Rediscovered in a Case Report
por: Fantozzi, Pamela, et al.
Publicado: (2022)

Postnatal therapeutic approaches in genetic neurodevelopmental disorders
por: Levy, Gilad, et al.
Publicado: (2020)

The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders
por: Morato Torres, C. Alejandra, et al.
Publicado: (2020)

Role of Ash1l in Tourette syndrome and other neurodevelopmental disorders
por: Zhang, Cheng, et al.
Publicado: (2020)

Capacity of the CCC-2 to Discriminate ASD from Other Neurodevelopmental Disorders
por: de la Torre Carril, Alba, et al.
Publicado: (2021)

Inflammatory Conditions During Pregnancy and Risk of Autism and Other Neurodevelopmental Disorders
por: Croen, Lisa A., et al.
Publicado: (2023)

ErbB4 in Laminated Brain Structures: A Neurodevelopmental Approach to Schizophrenia
por: Perez-Garcia, Carlos G.
Publicado: (2015)

Optimization of Genome Engineering Approaches with the CRISPR/Cas9 System
por: Li, Kai, et al.
Publicado: (2014)

Type II CRISPR/Cas9 approach in the oncological therapy
por: Biagioni, A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dvrmmccep6isllmn23dso287r5